Related Experiment Video
Updated: May 5, 2026

12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.8K
Effect of Age on Robotic-Assisted Radical Prostatectomy Outcomes: A Multi-center Analysis.
Alec Zhu1, Amy L Tin2, Andrew J Vickers2
1Department of Urology, New York Presbyterian Hospital - Weill Cornell Medical Center, New York, NY.
Urology
|May 11, 2025
Summary
Older age slightly increases complication risk after robotic prostatectomy, but the absolute risk remains low. Age alone should not deter treatment for well-selected older prostate cancer patients.
Area of Science:
- Urology
- Surgical Oncology
- Geriatric Medicine
Background:
- Robotic-assisted radical prostatectomy is a common treatment for prostate cancer.
- Age is a known risk factor for surgical complications.
- The clinical significance of age-related risk in robotic prostatectomy is not well-defined.
Purpose of the Study:
- To evaluate the association between patient age and perioperative complications after robotic-assisted radical prostatectomy.
- To determine if age-related increases in complication risk are clinically significant.
Main Methods:
- Pooled data from three institutions (Cornell, Georgetown, Memorial Sloan Kettering) from 2012-2022.
- Assessed major complications (Clavien-Dindo grade ≥3) within 30 days post-surgery.
- Used multivariable regression, adjusting for surgeon volume and oncologic risk factors.
Main Results:
- Overall major complication rates were similar across institutions (2.1-4.1%).
- Older age was associated with a statistically significant increased risk of complications (OR 1.03 per year).
- The absolute increase in risk was small; estimated risk for 60, 70, and 80-year-olds was 2.0%, 2.6%, and 3.3%, respectively.
Conclusions:
- Older age is associated with a slightly increased risk of major complications after robotic prostatectomy.
- The absolute increase in complication risk with age is not clinically significant.
- Age alone should not be the deciding factor for treatment in well-selected older prostate cancer patients.

